Subjects n | 11 | 12 | | |
Non-corrected F2-isoprostanes ng·mL−1 | 3.1±1.3 | 3.4±1.4 | 3.2±1.4 | 2.2±0.8 | −1.3 (−2.4–−0.1) | 0.03 |
Creatinine mmol·L−1 | 13.8±10.5 | 13.8±10.6 | 11.3±4.3 | 8.4±2.9 | −3.0 (−8.0–1.9) | 0.21 |
Urine volume mL | 814±497 | 889±569 | 699±312 | 988±335 | 205 (−88–499) | 0.16 |
Urinary excretion rate mL·h−1 | 78.1±43.1 | 83.9±53.2 | 57.0±31.1 | 86.7±28.5 | 18.9 (−12.3–50.1) | 0.22 |
Corrected F2-isoprostanes/creatinine ratio ng·μmol−1 | 0.31±0.18 | 0.37±0.19 | 0.29±0.11 | 0.27±0.07 | −0.1 (−0.23–0.03) | 0.11 |
F2-isoprostanes production corrected by urine excretion rate ng·h−1 | 216.6±120.7 | 251.7±145.8 | 168.2±116.3 | 182.8±78.7 | −56.9 (−161.0–47.2) | 0.26 |